Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$571M |
| 2 |
Medtronic
MDT
|
+$429M |
| 3 |
Citigroup
C
|
+$412M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$408M |
| 5 |
Gilead Sciences
GILD
|
+$397M |
Top Sells
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.47B |
| 2 |
Amazon
AMZN
|
+$1.35B |
| 3 |
Apple
AAPL
|
+$1.14B |
| 4 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.03B |
| 5 |
Bank of America
BAC
|
+$718M |
Sector Composition
| 1 | Technology | 16.46% |
| 2 | Healthcare | 15.78% |
| 3 | Consumer Discretionary | 11.75% |
| 4 | Financials | 11.25% |
| 5 | Industrials | 8.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SRCL
601
DELISTED
Stericycle Inc
SRCL
| $34.6M | 0.01% |
+566,590
| New | +$34.6M |
|
|
QXO
602
QXO Inc
QXO
$14.3B
| $34.5M | 0.01% |
2,190,249
-7,110,834
| -76% | -$112M |
|
603
American Tower
AMT
$91.2B
| $34.5M | 0.01% |
148,341
+128,926
| +664% | +$30M |
|
604
Hims & Hers Health
HIMS
$10.9B
| $34.5M | 0.01% |
1,872,172
-310,042
| -14% | -$5.71M |
|
605
Nurix Therapeutics
NRIX
$692M
| $34.4M | 0.01% |
1,531,205
+490,539
| +47% | +$11M |
|
606
LivaNova
LIVN
$3.1B
| $34.2M | 0.01% |
651,756
-912,849
| -58% | -$48M |
|
607
NMI Holdings
NMIH
$3.08B
| $34.1M | 0.01% |
828,989
-126,484
| -13% | -$5.21M |
|
|
CMPS
608
Compass Pathways
CMPS
$484M
| $34.1M | 0.01% |
5,414,576
+1,746,360
| +48% | +$11M |
|
609
Whirlpool
WHR
$5.24B
| $34.1M | 0.01% |
318,654
+72,262
| +29% | +$7.73M |
|
610
Ralph Lauren
RL
$18.9B
| $34.1M | 0.01% |
175,664
-211,429
| -55% | -$41M |
|
611
APi Group
APG
$14.5B
| $34M | 0.01% |
1,542,921
+620,086
| +67% | +$13.7M |
|
|
VRNA
612
Verona Pharma
VRNA
$9.2B
| $33.9M | 0.01% |
1,178,022
+1,075,407
| +1,048% | +$30.9M |
|
613
BILL Holdings
BILL
$5.38B
| $33.9M | 0.01% |
642,160
-498,924
| -44% | -$26.3M |
|
614
Corebridge Financial
CRBG
$17.9B
| $33.9M | 0.01% |
1,160,928
-4,943,195
| -81% | -$144M |
|
615
Fabrinet
FN
$13.2B
| $33.8M | 0.01% |
142,958
+26,894
| +23% | +$6.36M |
|
616
Agilent Technologies
A
$35.3B
| $33.7M | 0.01% |
227,066
-765,264
| -77% | -$114M |
|
617
ProShares Ultra QQQ
QLD
$9.13B
| $33.7M | 0.01% |
334,725
+260,645
| +352% | +$26.2M |
|
618
Dentsply Sirona
XRAY
$2.74B
| $33.7M | 0.01% |
1,244,484
+644,640
| +107% | +$17.4M |
|
619
Datadog
DDOG
$48.7B
| $33.6M | 0.01% |
291,684
-2,159,647
| -88% | -$248M |
|
620
Consumers Staples Select Sector SPDR Fund
XLP
$16B
| $33.4M | 0.01% |
402,709
+154,961
| +63% | +$12.9M |
|
621
IDEAYA Biosciences
IDYA
$2.16B
| $33.3M | 0.01% |
1,052,381
-426,942
| -29% | -$13.5M |
|
|
SUM
622
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $33.2M | 0.01% |
851,618
-768,699
| -47% | -$30M |
|
623
Radian Group
RDN
$4.74B
| $33.2M | 0.01% |
956,847
+119,077
| +14% | +$4.13M |
|
624
IQVIA
IQV
$31.4B
| $33.1M | 0.01% |
139,517
-173,572
| -55% | -$41.1M |
|
625
Cullinan Oncology
CGEM
$388M
| $32.7M | 0.01% |
1,955,257
+12,118
| +0.6% | +$203K |
|